Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]

Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)] Publisher Pubmed

Alibolandi M¹ ; Sadeghi F^{2, 3} ; Abnous K⁴ ; Atyabi F⁵ ; Ramezani M^{4, 6} ; Hadizadeh F¹

Show Affiliations

1. Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2. Targeted Drug Delivery Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
3. Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
4. Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
5. Nanothechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
6. Nanothechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Source: European Journal of Pharmaceutics and Biopharmaceutics Published:2025

Abstract

Unfortunately, we noticed that we made unintentional mistakes in two of our figures (Figure 2 and Figure 10). We should emphasize that this mistake did not impact integrity and conclusion of the paper. We truly apologize for any inconvenience this may have caused. In Figure 2A and Figure 2B were inadvertently duplicated in a completely random manner during the panel preparation, owing to their remarkable similarity. The correct image was as follows: In Figure 10, some overlaps were detected which unintentionally occurred due to the mislabeling of the images. As resolving this issue is very important, the paraffinized blocks of organs were sectioned, stained and images were accurately prepared. We did this renewal for all panels because the previous images were taken with our old laboratory camera and in order to obtain consistency in the quality of image panels, we re-imaged all organs. The corrected new images are as follow: Thank you in advance for your kind attention and cooperation. © 2024 Elsevier B.V.

Style	Citing Format
MLA	Alibolandi M, et al.. "Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]." European Journal of Pharmaceutics and Biopharmaceutics, vol. 206, no. , 2025, pp. -.
APA	Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F (2025). Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]. European Journal of Pharmaceutics and Biopharmaceutics, 206(), -.
Chicago	Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. "Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]." European Journal of Pharmaceutics and Biopharmaceutics 206, no. (2025): -.
Harvard	Alibolandi M et al. (2025) 'Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]', European Journal of Pharmaceutics and Biopharmaceutics, 206(), pp. -.
Vancouver	Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]. European Journal of Pharmaceutics and Biopharmaceutics. 2025;206():-.
BibTex	@article{ author = {Alibolandi M and Sadeghi F and Abnous K and Atyabi F and Ramezani M and Hadizadeh F}, title = {Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]}, journal = {European Journal of Pharmaceutics and Biopharmaceutics}, volume = {206}, number = {}, pages = {-}, year = {2025} }
RIS	TY - JOUR AU - Alibolandi M AU - Sadeghi F AU - Abnous K AU - Atyabi F AU - Ramezani M AU - Hadizadeh F TI - Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)] JO - European Journal of Pharmaceutics and Biopharmaceutics VL - 206 IS - SP - EP - PY - 2025 ER -

Style

Citing Format

MLA

Alibolandi M, et al.. "Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]." European Journal of Pharmaceutics and Biopharmaceutics, vol. 206, no. , 2025, pp. -.

APA

Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F (2025). Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]. European Journal of Pharmaceutics and Biopharmaceutics, 206(), -.

Chicago

Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. "Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]." European Journal of Pharmaceutics and Biopharmaceutics 206, no. (2025): -.

Harvard

Alibolandi M et al. (2025) 'Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]', European Journal of Pharmaceutics and Biopharmaceutics, 206(), pp. -.

Vancouver

Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]. European Journal of Pharmaceutics and Biopharmaceutics. 2025;206():-.

BibTex

@article{ author = {Alibolandi M and Sadeghi F and Abnous K and Atyabi F and Ramezani M and Hadizadeh F}, title = {Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]}, journal = {European Journal of Pharmaceutics and Biopharmaceutics}, volume = {206}, number = {}, pages = {-}, year = {2025} }

RIS

TY - JOUR
AU - Alibolandi M
AU - Sadeghi F
AU - Abnous K
AU - Atyabi F
AU - Ramezani M
AU - Hadizadeh F
TI - Corrigendum “The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model” [Eur. J. Pharm. Biopharm. 94 (2015) 521–531, (S0939641115002945), (10.1016/J.Ejpb.2015.07.005)]
JO - European Journal of Pharmaceutics and Biopharmaceutics
VL - 206
IS -
SP -
EP -
PY - 2025
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract